Posts Tagged 'Actos and bladder cancer'

Hissey Kientz publishes frequently asked questions for Actos bladder cancer

Hissey Kientz law firm has published a frequently asked questions section to provide more information about the diabetes medication Actos and bladder cancer to readers. The FAQs include information concerning who should not take Actos and certain risks associated with the drug.

Read more about the connection between Actos and bladder cancer…

Doctor warns of pharmaceutical company influence on data in new book

A prominent doctor and former Secretary of the British Association for Psychopharmacology warns of pharmaceutical companies manipulating data in a new book called “Pharmageddon.” Dr. David Healy argues in the book that companies like GlaxoSmithKline and Takeda Pharmaceuticals outsource clinical trials and hide data from health agencies.

Read more about data manipulation by pharmaceutical companies…

Actos doubles bladder cancer risk, British study finds

A new study has confirmed that the diabetes medication Actos doubles the risk of developing bladder cancer among people who use the drug for at least two years. The Canadian study was published in the British Medical Journal (BMJ) and included more than 115,000 diabetes patients that were treated between 1988 and 2009.

Read more about Actos and bladder cancer…

Actos users with bladder cancer may qualify for a lawsuit

Patients who used the diabetes drug Actos and developed bladder cancer may qualify to file a lawsuit against the manufacturer of the drug. Multiple studies have warned that patients taking Actos may face an increased risk of developing bladder cancer.

Read more about Actos lawsuits…

Experts weigh Actos alternatives after cancer warning

Two new reports filed by the American College of Physicians and Consumer Reports have found that taking an alternative to the diabetes drug Actos has significant advantages for type II diabetes patients. The physicians found that diabetes medication metformin—which has existed for nearly two decades—is both cheaper and safer than Actos.

Read more about alternatives to Actos…

Actos maker hid safety info from FDA, whistleblower lawsuit claims

A whistleblower lawsuit alleges that the manufacturer of the diabetes drug Actos misrepresented and hid safety information from the Food and Drug Administration. Helen Ge claims in her Actos lawsuit that Takeda Pharmaceuticals directed its staff to not classify non-hospitalized or non-fatal cases of congestive heart failure in Actos patients as serious.

Click here to read more…

First hearing date set in Louisiana Actos bladder cancer lawsuits

A judge in Louisiana has set a date for the first hearing in dozens of Actos bladder cancer lawsuits that are set to be heard in the state’s federal court. Judge Rebecca Doherty said that she plan to appoint head lawyers for the cases after a hearing in her Lafayette, Louisiana courtroom on March 22.

Click here to read more…


Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 437 other followers

Contact Us:

Hissey Kientz, LLP

9442 Capital of Texas Hwy N.

Arboretum Plaza One, Suite 400

Austin, Texas 78759

Toll-free: (866) 275-4454

Facsimile: (512) 320-9101

Email: info@hkllp.com

Sponsored By:

Hissey Kientz, LLP (Austin, TX)

Attorney Michael Hissey is responsible for the content of this website.